Skip to main content

Table 3 Clinical information received by the patients

From: Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain

  n %
Did you receive information about your disease before starting the treatment with the allergen immunotherapy tablet? (n = 128)
Yes, in detail 114 89.1
Yes, a little 14 10.9
Did you receive information about the different treatments for your disease? (n = 129)
Yes, in detail 102 79.1
Yes, a little 25 19.4
I received no information 2 1.6
Did you receive information about the characteristics of the allergen immunotherapy tablet? (n = 128)
Yes, in detail 107 83.6
Yes, a little 20 15.6
I received no information 1 0.8
Did you receive written information about your disease or its treatment? (n = 128)
Yes 58 45.3
No 70 54.7